Bradley C. Martin
Professor
University of Arkansas for Medical Sciences
faculty
Pharmacy Practice, College of Pharmacy
Research Areas
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Bradley C. Martin's research focuses on health outcomes and the application of data science in healthcare. He has investigated the associations between early chiropractic and physical therapy on subsequent opioid use in individuals with low back pain, and explored trajectories of opioid coverage among veterans. His work also examines real-world survival rates for first-line immune checkpoint inhibitor treatment versus chemotherapy in older patients with non–small-cell lung cancer and synchronous brain metastases. Additionally, Martin studies adherence to extended venous thromboembolism prophylaxis and outcomes following complex gastrointestinal oncologic surgery.
Further research by Martin includes utilizing data science to improve outcomes for individuals with opioid use disorder and exploring perceptions of HPV vaccination and pharmacist-physician collaboration models to enhance vaccination rates. He has also published on the association between discontinuing chronic opioid therapy and newly diagnosed substance use disorders, accidents, self-inflicted injuries, and drug overdoses. A pilot study led by Martin investigated opioid overdose counseling and naloxone prescribing in rural community pharmacies.
Martin holds a highly cited researcher designation, with an h-index of 50 and over 257 publications that have garnered more than 11,713 citations. He leads a research group and maintains an active lab website. His key collaborators at the University of Arkansas for Medical Sciences include Corey J. Hayes, Chenghui Li, Jacob T. Painter, and Mahip Acharya.
Metrics
- h-index: 50
- Publications: 257
- Citations: 11,713
Selected Publications
- Venous thromboembolism diagnosis definition in claims data: implications for research (2025) DOI
- Disparities in Extended Venous Thromboembolism Prophylaxis After Pancreatic Cancer Surgery (2025) DOI
- Clinical outcomes of extended venous thromboembolism prophylaxis after oncologic colorectal surgery (2025) DOI
- An updated view on the influence of initial opioid prescription characteristics on long-term opioid use among opioid naïve patients (2024) DOI
- The role of prescribed controlled substance acquisition as potential triggers of opioid overdose: A case-crossover study (2024) DOI
- A Statewide Examination of Medical Cannabis Purchasing Patterns in Arkansas Over the Three Years Immediately Following Legalization (2024) DOI
- Average Daily Dose Trajectories for Episodes of Buprenorphine Treatment for Opioid Use Disorder. (2024) DOI
- Are gaps in rates of retention on buprenorphine for treatment of opioid use disorder closing among veterans across different races and ethnicities? A retrospective cohort study (2024) DOI
- Immune checkpoint inhibitors as subsequent treatment in older adults with non-small cell lung cancer and synchronous brain metastases (2024) DOI
- Development and validation of machine-learning algorithms predicting retention, overdoses, and all-cause mortality among US military veterans treated with buprenorphine for opioid use disorder (2024) DOI
- In-Hospital Mortality by Race and Ethnicity Among Hospitalized COVID-19 Patients Using Data From the US National COVID Cohort Collaborative (2024) DOI
- Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations (2024) DOI
- The association between suspected long–COVID and stimulant prescribing in the United States (2023) DOI
- Clinical Observation, Management and Function Of low back pain Relief Therapies (COMFORT): A cluster randomised controlled trial protocol (2023) DOI
- Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non–Small-Cell Lung Cancer and Synchronous Brain Metastases (2023) DOI
Grants & Funding
- Impact of Opioid Dosing Strategies on Pain Scores and Adverse or Unintended Clinical Outcomes NIH Co-Investigator
- The influence of post-partum coverage extension on maternal depression screening NIH/Nat. Inst. of Child Health & Human Development - Pass Through: Tulane University Principal Investigator
- Arkansas Consortium for Health Services Research NIH Principal Investigator
- Prescribers, Pharmacists, and the Opioid Dilemma NIH/Nat. Inst. on Drug Abuse - Pass Through: RTI, International Co-Investigator
- Use and Abuse of Prescription Opioids Among OEF/OIF Veterans NIH Co-Investigator
- Early Care Decisions and the Risk of Long-Term Opioid Use in Patients with Low Back Pain UAMS Intramural Grant (CTSA) Principal Investigator
- ADVANCING RISK ADJUSTMENT FOR SCHIZOPHRENIA NIH Principal Investigator
- Utilization Patterns and Persistence of Antihormonal Therapies for Breast Cancer NOVARTIS Pharmaceuticals Corporation Principal Investigator
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics